SMIM1 is a type II transmembrane phosphoprotein and displays the Vel blood group antigen at its carboxyl-terminus

FEBS Lett. 2015 Nov 30;589(23):3624-30. doi: 10.1016/j.febslet.2015.09.029. Epub 2015 Oct 9.

Abstract

Disruption of SMIM1, encoding small integral membrane protein 1, is responsible for the Vel-negative blood type, a rare but clinically-important blood type. However, the exact nature of the Vel antigen and how it is presented by SMIM1 are poorly understood. Using mass spectrometry we found several sites of phosphorylation in the N-terminal region of SMIM1 and we found the initiating methionine of SMIM1 to be acetylated. Flow cytometry analyses of human erythroleukemia cells expressing N- or C-terminally Flag-tagged SMIM1, several point mutants of SMIM1, and a chimeric molecule between Kell and SMIM1 demonstrated that SMIM1 carries the Vel antigen as a type II membrane protein with a predicted C-terminal extracellular domain of only 3-12 amino acids.

Keywords: Blood group; Mass spectrometry; Phosphorylation; Small integral membrane protein; Type II membrane protein.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Amino Acid Sequence
  • Blood Group Antigens / chemistry*
  • Blood Group Antigens / metabolism*
  • Cell Membrane / metabolism
  • Extracellular Space / metabolism
  • HEK293 Cells
  • Humans
  • K562 Cells
  • Membrane Proteins / chemistry
  • Membrane Proteins / metabolism*
  • Molecular Sequence Data
  • Phosphoproteins / chemistry
  • Phosphoproteins / metabolism*

Substances

  • Blood Group Antigens
  • Membrane Proteins
  • Phosphoproteins
  • SMIM1 protein, human